These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6416698)

  • 61. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
    Schulman C; Sylvester R; Robinson M; Smith P; Lachand A; Denis L; Pavone-Macaluso M; De Pauw M; Staquet M
    Recent Results Cancer Res; 1978; 68():338-45. PubMed ID: 111322
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
    Groos E; Walker L; Masters JR
    Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

  • 67. The role of epipodophyllotoxin derivatives in bladder cancer.
    Serretta V; Ingargiola GB; Pavone-Macaluso M
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):81-4. PubMed ID: 1411641
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Intravesical instillation of adriamycin and other antineoplastic agents].
    Matsumura Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):372-6. PubMed ID: 7184406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Intravesical chemotherapy in superficial tumors of the bladder].
    Schulman CC
    Arch Esp Urol; 1983; 36(1):32-40. PubMed ID: 6409013
    [No Abstract]   [Full Text] [Related]  

  • 70. [Which intravesical chemotherapy for what tumor of the bladder?].
    Bouffioux C; Denis L; Kurth KH; De Pauw M; Sylvester R
    J Urol (Paris); 1988; 94(5-6):251-60. PubMed ID: 3058811
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR-Bt: a randomized controlled trial.
    Matsushima H; Kawabe K; Fujime M; Kitamura T; Homma Y; Kishi H; Kawamura T; Umeda T; Ohishi Y; Murai M; Kawai T; Yoshida H; Fukuda T
    Oncol Rep; 2002; 9(2):283-8. PubMed ID: 11836593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J; Kühnel W; Dona S
    Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
    Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
    J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

  • 75. Intravesical chemotherapy in the United States. An overview.
    Spaulding JT
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S5-8. PubMed ID: 6196136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic therapy for superficial bladder cancer.
    Soloway MS
    Urology; 1984 Apr; 23(4 Suppl):88-93. PubMed ID: 6369722
    [No Abstract]   [Full Text] [Related]  

  • 78. [Prophylactic intravesical instillation therapy with adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer].
    Ozaki Y; Tsushima T; Nasu Y; Akagi T; Obama T; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1493-500. PubMed ID: 3100850
    [No Abstract]   [Full Text] [Related]  

  • 79. A controlled trial of single dose intravesical adriamycin in superficial bladder tumours.
    Abrams PH; Choa RG; Gaches CG; Ashken MH; Green NA
    Br J Urol; 1981 Dec; 53(6):585-7. PubMed ID: 7032640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.